Enthera
PrivateLast Round
Series A
Jan 28, 2021
Total Funding Raised
$47.1M
Company Overview
Enthera is a biopharmaceutical company that develops first-in-class biologics for the treatment of autoimmune disorders, including Type 1 Diabetes and Inflammatory Bowel Disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enthera Comparables
Compare Enthera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acelyrin | 74% | |
| EnteroTarget ApS | 71% | |
| Sanofi | 70% | |
Enthera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 28, 2021 | ||||
| Seed | Jul 24, 2018 | ||||
| Seed | Nov 23, 2016 | ||||
| Seed | Oct 1, 2016 |
Key People
Founding team and executive leadership
Enthera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Banca Profilo S.p.A. | Series A |
| Roche Venture Fund | Series A |
| Indaco Venture Partners SGR | Series A |
| AbbVie Ventures | Series A |
| Roche Venture Fund | Series A |
| JDRF | Seed, Series A |
| Sofinnova Partners | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2021
$42M round led by AbbVie Ventures, Roche Venture Fund, and Sofinnova Partners.
- Jul 24, 2018
$4.7M round led by Sofinnova Partners
Enthera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enthera's valuation, stock price, and market status.